Zhengxu Biotechnology

Developer of gene-editing technology to treat genetic diseases

placePudong, Shanghai, China calendar_todayFounded 2020 language correctsequence.com

Social engagement

Social engagement: 426 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Lilly Asia Ventures, Boyu Capital.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%

Recent activity

11 May 2026
Event
American Society of Gene & Cell Therapy 2026 Annual Meeting (#ASGCT2026)
Coming soon